These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1205 related items for PubMed ID: 10213511

  • 1. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone.
    Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A.
    Cancer Res; 2001 Mar 01; 61(5):2177-82. PubMed ID: 11280783
    [Abstract] [Full Text] [Related]

  • 3. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H, Kanomata N, Goya M, Kamijo T, Yokose T, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A.
    Cancer Res; 2003 May 01; 63(9):2096-102. PubMed ID: 12727825
    [Abstract] [Full Text] [Related]

  • 4. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC.
    Prostate; 2008 Jan 01; 68(1):92-104. PubMed ID: 18008334
    [Abstract] [Full Text] [Related]

  • 5. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N, Gleave ME, Bruchovsky N, Rennie PS, Beraldi E, Sullivan LD.
    Cancer Res; 1997 Apr 15; 57(8):1584-9. PubMed ID: 9108464
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
    Goya M, Miyamoto S, Nagai K, Ohki Y, Nakamura K, Shitara K, Maeda H, Sangai T, Kodama K, Endoh Y, Ishii G, Hasebe T, Yonou H, Hatano T, Ogawa Y, Ochiai A.
    Cancer Res; 2004 Sep 01; 64(17):6252-8. PubMed ID: 15342412
    [Abstract] [Full Text] [Related]

  • 7. Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse.
    Soos G, Jones RF, Haas GP, Wang CY.
    Anticancer Res; 1997 Sep 01; 17(6D):4253-8. PubMed ID: 9494517
    [Abstract] [Full Text] [Related]

  • 8. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 9. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
    Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y.
    Prostate; 2004 Mar 01; 58(4):406-13. PubMed ID: 14968441
    [Abstract] [Full Text] [Related]

  • 10. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
    Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW.
    Cancer Res; 1991 Jul 15; 51(14):3753-61. PubMed ID: 1712249
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.
    Cancer Res; 2001 Jul 15; 61(14):5652-9. PubMed ID: 11454720
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.
    Clin Cancer Res; 2003 Jul 15; 9(7):2587-97. PubMed ID: 12855635
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
    Singh AS, Macpherson GR, Price DK, Schimel D, Figg WD.
    Oncol Rep; 2006 Mar 15; 15(3):519-24. PubMed ID: 16465406
    [Abstract] [Full Text] [Related]

  • 14. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 15; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 15. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
    Yonou H, Ochiai A, Ashimine S, Maeda H, Horiguchi Y, Yoshioka K, Ogawa Y, Hatano T, Tachibana M.
    Prostate; 2007 Jun 15; 67(9):999-1009. PubMed ID: 17440967
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.
    Bone; 2006 Feb 15; 38(2):154-66. PubMed ID: 16126463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.
    Cancer Res; 2001 Aug 15; 61(16):6012-9. PubMed ID: 11507044
    [Abstract] [Full Text] [Related]

  • 19. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS, Ahluwalia R, Zhang X, Conrad H, Emmanouilides C.
    Int J Oncol; 2003 Dec 15; 23(6):1569-74. PubMed ID: 14612928
    [Abstract] [Full Text] [Related]

  • 20. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL, Dai J, van Golen KL, Keller ET, Long MW.
    Cancer Res; 2006 Sep 01; 66(17):8648-54. PubMed ID: 16951179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.